Impact of Using an Hemodynamic Monitoring System on Anesthetic Consumption During Abdominal Surgery
HERMES
1 other identifier
interventional
84
1 country
1
Brief Summary
In this study investigators will study the association between the use of an hemodynamic monitoring system and the anesthetic consumption in patients following major abdominal surgery. Investigators will randomise patients for a control group and an intervention group. Patients belonging to intervention group will be monitored with a non-invasively continue system (Acumen IQ cuff sensor), while the control group will be monitored with a non-invasive intermittent pressure system. The total amount of mL of Sevoflurane will be registered in both groups and the difference will be considered as the aim of our study
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 22, 2024
CompletedFirst Posted
Study publicly available on registry
June 3, 2024
CompletedStudy Start
First participant enrolled
July 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedAugust 22, 2025
August 1, 2025
10 months
May 22, 2024
August 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Reduction in Anesthetic consumption
During surgery
Secondary Outcomes (2)
number hypotensive episodes
during surgery
duration hypotensive episodes
during surgery
Study Arms (2)
Intervention
EXPERIMENTALIn this group we will use a continuous non-invasive hemodynamic monitoring system (Acumen IQ cuff)
Control
NO INTERVENTIONIn this group we will use the oscillometric non-invasive blood pressure monitoring system
Interventions
Eligibility Criteria
You may qualify if:
- over 18 years of age
- signature of informed medical consent
You may not qualify if:
- BMI\> 30
- eGFR\<30
- NYHA III-IV
- severe cardiac valvular diseases
- absence of informed medical consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fondazione Policlinico Universitario "A. Gemelli" IRCCS
Roma, Roma, 00168, Italy
Study Officials
- PRINCIPAL INVESTIGATOR
Andrea Russo, MD
Fondazione Policlinico universitario Agostino Gemelli
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
May 22, 2024
First Posted
June 3, 2024
Study Start
July 1, 2024
Primary Completion
May 1, 2025
Study Completion
June 1, 2025
Last Updated
August 22, 2025
Record last verified: 2025-08